Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
- World rank, all time
- #37,971 of 42,892
- Rank in Germany
- #1,823 of 2,077
- Research works
- 134 ▼ 8% vs 2013–17
- Citations
- 2.4k 18.2 per fractional work
- Top-10% rate
- 13.0% record average 16.5%
- Open access
- 30% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 4.4×. Every wedge is a field page.
- Economics, Econometrics and Finance 4.4×
- Business, Management and Accounting 2.6×
- Decision Sciences 2.4×
- Arts and Humanities 2.2×
- Medicine 2.0×
- Neuroscience 1.1×
- Health Professions 1.0×
- Computer Science 0.9×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Agricultural and Biological Sciences 0.8×
- Social Sciences 0.8×
- Environmental Science 0.6×
- Immunology and Microbiology 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Engineering 0.1×
- Psychology 0.1×
- Physics and Astronomy 0.1×
- Mathematics 0.0×
Who are the top researchers at Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe?
Ranked on the composite score, Belz Gg lead among researchers whose main affiliation is Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe.
- 1 Belz Gg Germany · #1,544,753 worldwide 5 citations · 15 works
Which keywords describe research at Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Cytoreductive Surgery, Clinical Trials, Biomarkers, Metastasis, Ovarian Cancer, Genomic Analysis and Mutation Analysis.
- Homologous Recombination
- Neurotoxicity
- Metastatic Breast Cancer
- Patient Rights
- Informed Consent
- Targeted Therapy
- Treatment Response
- Gastric Cancer
- Breast Cancer
- Prognostic Markers
- Molecular Subtypes
- Radiation Therapy
- Brachytherapy
- Quality of Life
- Cervical Cancer
- Survival Analysis
- Mutation Analysis
- Ovarian Cancer
- Biomarkers
- Clinical Trials
- Chemotherapy
- Cytoreductive Surgery
- Metastasis
- Genomic Analysis
- Tumor Models
- Clinical Practice Guidelines
- Genetic Testing
- Molecular Classification
- Endometrial Carcinoma
- Immunotherapy
- Neoadjuvant Therapy
- Radiotherapy
- Gene Expression
- Breast Tumours
- Molecular Characterization
- Colorectal Cancer
- Medical Ethics
- Cancer Risk
- Intraperitoneal Chemotherapy
- Peritoneal Metastases
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy18▲ 19×14 topics
- Clinical Trials16▲ 19×7 topics
- Cytoreductive Surgery16▲ 181×2 topics
- Biomarkers16▲ 19×6 topics
- Metastasis15▲ 33×6 topics
- Ovarian Cancer15▲ 120×3 topics
- Genomic Analysis14▲ 35×2 topics
- Mutation Analysis14▲ 137×1 topic
- Tumor Models14▲ 168×1 topic
- Survival Analysis10▲ 29×4 topics
- Clinical Practice Guidelines10▲ 13×10 topics
- Cervical Cancer5▲ 38×2 topics
- Genetic Testing5▲ 24×4 topics
- Quality of Life5▲ 2.8×16 topics
- Molecular Classification5▲ 25×2 topics
- Brachytherapy5▲ 91×1 topic
- Endometrial Carcinoma5▲ 91×1 topic
- Radiation Therapy5▲ 23×2 topics
- Immunotherapy4▲ 4.4×8 topics
- Molecular Subtypes4▲ 32×2 topics
- Neoadjuvant Therapy4▲ 12×4 topics
- Prognostic Markers4▲ 28×3 topics
- Radiotherapy3▲ 6.7×5 topics
- Breast Cancer3▲ 8.4×9 topics
- Gene Expression3▲ 3.9×5 topics
- Gastric Cancer3▲ 18×2 topics
- Breast Tumours3▲ 43×1 topic
- Treatment Response3▲ 43×1 topic
- Molecular Characterization3▲ 11×4 topics
- Targeted Therapy3▲ 9.2×5 topics
- Colorectal Cancer3▲ 20×2 topics
- Informed Consent3▲ 22×2 topics
- Medical Ethics3▲ 11×1 topic
- Patient Rights3▲ 20×1 topic
- Cancer Risk2▲ 6.8×2 topics
- Metastatic Breast Cancer2▲ 28×2 topics
- Intraperitoneal Chemotherapy2▲ 94×1 topic
- Neurotoxicity2▲ 9.6×3 topics
- Peritoneal Metastases2▲ 94×1 topic
- Homologous Recombination2▲ 24×2 topics
Which research topics does Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe publish most on?
By volume in 2022–2025: Ovarian cancer diagnosis and treatment, Reformation and Early Modern Christianity, PARP inhibition in cancer therapy and Endometrial and Cervical Cancer Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
- 2 Reformation and Early Modern Christianity History 1 works
- 3 PARP inhibition in cancer therapy Oncology 1 works
- 4 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 1 works
- 5 Ayn Rand and Brontë studies Economics and Econometrics 1 works
- 6 Corporate Social Responsibility and Sustainability Organizational Behavior and Human Resource Management 1 works
- 7 Brazilian Legal Issues Law 0 works
- 8 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
- 9 Agricultural Systems and Practices Ecology, Evolution, Behavior and Systematics 0 works
- 10 Balkan and Eastern European Studies Economics and Econometrics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe's research output changed?
Output in 2018–2022 was 8% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Wiesbaden
- Helios Dr. Horst Schmidt Kliniken Wiesbaden
- Hologic (Germany)
- RheinMain University of Applied Sciences
- EBS University of Business and Law
- Deutsche Klinik für Diagnostik
- Statistisches Bundesamt
- Abbott (Germany)
- St. Josefs Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.